I think it's because many have had to sell shares for

New Post Public Reply Private Reply Replies (2) Message Board
Shub lajet #3228
I think it's because many have had to sell shares for personal financial reasons. Sorry if I'm speaking out of my backside Tonto. I know that a lot of us really believed most of the information that we were hearing about this company from the NTEK team, so we took it as something that was in the works and believed the stock had the potential to increase exponentially. They obviously had no idea that shares were going to be down like they are, so the "dollar a share" bit was taken with a grain of salt for sure. However, they also knew damned well that some of the things they were saying were absolute falsehoods. So many here have had to sell shares at tremendous losses to cover various financial issues. It just galls me a little bit that there was no accountability for all the things those at NTEK were doing if you ask me.

I am completely on board with hoping the management changes and the company changes are able to bring this company back to the levels of trust we thought we should have with them in 2013, but I'm a little skeptical about that time with hindsight considering that we don't have any idea what was true and what was false. Some of the things they were supposed to be doing just kind of disappeared into the ether and we have no idea what happened. I'm really hoping there is *more* transparency, honestly, and communication. The SHL seemed like a good start, and I hope it continues along that same path.

Can I ask you a question? I know you went to the site and felt even more like this was a good investment. Was there anything in particular that has convinced you to continue to buy into the company after you went there despite all the things that are brought up on this board? I say this board because I think there are legitimate questions that get asked here, rather than straight-out bashing on the other site. Primarily we are all investors that want NTEK to do well, so we are questioning what is being told to the public. Even with the misinformation we have gotten over the years, what is still telling you that this is a good enough investment to continue to buy into it? Personally I do think it's got tremendous potential, but I also think that the practices over the past year or two has taken that potential down a few notches due to the misleading information they have given, or flat out lies that they have told us as well. NP-1 dates, Ciao, content availability...all these things are really good questions. I hope that things change drastically with the new CEO, but the content still isn't flowing like they said it would, and they still have content that's not available from a PR two months ago. I want them to succeed so we all succeed, but it does seem like they've been shooting their trustworthiness in the foot by telling us all these things were going to happen, then no one will say anything about them when questioned about it.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amgen's Board Gains Restaurateur Gibbs Amid Strategic Shift

Updated Category News Views 86

A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...

Continue Reading
AI's Rise: Worth Watching for M&A Strategy Insights

Updated Category News Views 0

AI: The Hot Topic You Can't Ignore AI's rocking the boat like SEO did back in the day, folks. The Digital WOW is giving M&A Source® members a real scoop with their exclusive webinar, zeroing in on AI's potential seismic shifts in mergers and acquisitions. This should make any investor sit up and pay attention. AI's not just a tech buzzword anymore. It's like a strong cup...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 72

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Texas Instruments' $2B Notes Fuel Acquisition Ambitions

Updated Category News Views 128

Pushing Forward with Big Dollars Texas Instruments is setting the stage with an ambitious move by pricing $2.0 billion in investment-grade notes, preparing to shake things up with an acquisition. It's not every day you see a player like TXN dipping into the bond market with such confidence, yet here we are. Four series of senior unsecured notes are slated for issuance on...

Continue Reading
E-Filing: Why Ditching IRS Paper Forms Matters Now

Updated Category News Views 153

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...

Continue Reading
Custom Concrete: Crafting the Perfect Poolside Paradise

Updated Category News Views 48

Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...

Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 116

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading
Energy Fuels Secures Key Financing for Donald Project

Updated Category News Views 53

Donald Project: A Step Closer to Reality Look, when those rare earths start moving, the entire market gets a whiff of promise. Energy Fuels' Donald Rare Earth and Mineral Sands Project in Australia is gearing up for real action with a fresh funding nod. Export Finance Australia and the National Reconstruction Fund Corporation have conditionally greenlit up to A$180...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 93

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Brennan Takes a Swing: Barrasso Endorsement in Hand

Updated Category News Views 60

Brennan Shakes Up Wyoming Politics You don’t need a crystal ball to see the chess game unfolding in Wyoming's political landscape. Shannon Brennan's bid for the House seat in Teton County's District 23 got a heavy artillery boost today. She’s landed the endorsement of Senator John Barrasso, none other than the Senate Majority Whip and a formidable player in the Senate...

Continue Reading

Top 5 Most Recently Viewed Articles

Rehabilitation Robots Market Growth and Future Opportunities

Updated Category News Views 187

The Future of Rehabilitation Robots As the healthcare landscape evolves, the rehabilitation robots market is witnessing remarkable growth, projected to reach approximately USD 1,776.24 million in the forthcoming years. This burgeoning sector aims to enhance the recovery processes for individuals across various age groups, especially the elderly, who often require...

Continue Reading
Kean University Strengthens Leadership with New Contract for Repollet

Updated Category News Views 152

Kean University’s New Chapter: A Strong Commitment to Leadership The Kean University Board of Trustees recently reached a pivotal decision about the university's future by approving a new five-year contract for President Lamont O. Repollet, Ed.D. This decision highlights the institution's dedication to transformative leadership as it works to enhance its reputation as a...

Continue Reading
Kura Sushi USA Prices Public Offering to Boost Growth Efforts

Updated Category News Views 327

Kura Sushi USA Public Offering Announcement Kura Sushi USA, Inc. (NASDAQ: KRUS), a pioneer in the technology-enabled Japanese dining experience, has recently priced a public offering of its Class A common stock. This strategic move is not just about fundraising; it reflects the Company's ambition to bolster its operational capacity and expand its reach. The offering...

Continue Reading
Grady Health System Receives Gold Plus Award for Excellence

Updated Category News Views 192

Grady Health System's Recognized Commitment to Stroke Care Grady Health System, home to the renowned Marcus Stroke and Neuroscience Center, has achieved the prestigious Gold Plus quality achievement award from the American Heart Association's Get With The Guidelines - Stroke program. This accolade highlights Grady's unwavering dedication to delivering exceptional stroke...

Continue Reading
Investors Urged to Act as Visa Faces Legal Challenges

Updated Category News Views 108

Investors Encouraged to Step Forward Amid Legal Investigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson is reaching out to investors who have suffered losses exceeding $100,000 in Visa to discuss their legal options directly. If you have experienced losses greater than $100,000 in Visa, it's essential to take action. You can connect with...

Continue Reading